News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Myriam Chalabi: Great Overview by Michael Overman of pMMR CRC
Michael Overman and Myriam Chalabi
Jul 7, 2025, 05:32

Myriam Chalabi: Great Overview by Michael Overman of pMMR CRC

Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek, shared on X:

“Great overview by Michael Overman of pMMR CRC and efforts to modulate for immunotherapy response. Important to learn from negative studies, but also consider that responses might be different in earlier disease stages.”

Myriam Chalabi

More posts featuring ESMOGI25.

cancer CRC disease stages ESMOGI25 immunotherapy Michael Overman Myriam Chalabi OncoDaily Oncology pMMR
Special Coverage
Voices
Aug 21, 2025, 14:07
NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial
Voices
Aug 21, 2025, 14:06
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute is Expanding its Clinical Research Team
Voices
Aug 21, 2025, 14:01
IU Simon Cancer Center Engages 1,800 Fairgoers at Indiana State Fair
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts